MVT: In the News

Sep 16

Microvascular Therapeutics and Cordance Medical Announce Strategic Partnership

Tucson, AZ & Mountain View, CA – Microvascular Therapeutics (MVT), a pioneering healthcare research and development company, is pleased...

Sep 12

MVT and Soundjet Announce Collaboration Aiming to Bring New Treatment Options to Patients with Vascular Thrombosis

Microvascular Therapeutics, Inc. (MVT), and SoundJet Medical, Inc. (SoundJet) announce that they have entered into a strategic...

Sep 5

Microvascular Therapeutics Announce Completion of Phase 2 Study Enrollment for MVT-100

Tucson, AZ – Microvascular Therapeutics (MVT), a pioneering healthcare research and development company, is pleased to announce the...

Sep 4

MVT’s Founder, Dr. Evan Unger, Receives 2024 Harry Fischer Award for Excellence in Contrast Media Research

Tucson, AZ - Dr. Evan Unger, CEO and Founder of Microvascular Therapeutics (MVT), has been awarded the 2024 Harry Fischer Award by...

Feb 9

Microvascular Therapeutics selected as a Participant in the 2024 Landmark Venture Forum

Microvascular Therapeutics selected as a Participant in the 2024 Landmark Venture Forum [Tucson, AZ] – Microvascular Therapeutics Inc....

Feb 8

Microvascular Therapeutics welcomes Thom Tulip as Chief Business Officer

[Tucson, Arizona] – [2/05/2024] – Microvascular Therapeutics Inc. (MVT), a clinical-stage biotech company at the forefront of developing...

Dec 12, 2023

Microvascular Therapeutics Selected as a Participant in the 2023 H7 BioCapital Accelerator Program

Microvascular Therapeutics (MVT), a clinical stage biopharma pioneering the potential of ultrasound in diagnostics and theranostics, has...

Dec 12, 2023

Breakthrough Study by Microvascular Therapeutics Reveals Fibrin-Targeted Phase Shift Microbubbles as

Microvascular Therapeutics, a trailblazing healthcare research and development company, announces a groundbreaking study on the treatment...

Oct 24, 2023

Microvascular Therapeutics receives $3.98M Award from CDMRP

Jan 25, 2023

Our CEO, Evan Unger is recognized by the journal "Radiology"

Nov 30, 2022

David Lim named as our Director of Finance

Nov 30, 2022

Marty Rosenberg joins our Scientific Advisory Board

Nov 21, 2022

MVT awarded Phase I SBIR grant from the NCI

Apr 21, 2022

Microvascular Therapeutics Finalizes Facility Certification for the Production of MVT-100.

Apr 11, 2022

Microvascular Therapeutics receives funds from Commercialization Readiness Program

Feb 28, 2022

Timothy Healey Joins the Board of Directors at Microvascular Therapeutics

Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of Timothy...

Feb 10, 2022

Evan C. Unger Receives Radiology Editor's Recognition Award

Feb 8, 2022

ImaRx Investments Receives ISO-7 Certification for Its GMP Manufacturing Suite

ImaRx Investments, LLC, an investment firm based in Tucson, Arizona, has received ISO-7 certification on February 1st for its GMP...

Feb 3, 2022

Shiv Kapoor Joins the Board of Directors at Microvascular Therapeutics

Jul 30, 2021

Microvascular Therapeutics Has Received Funds from the National Heart, Lung and Blood Institute